Dr. Mathew J. Thayer's lab focuses on understanding the molecular and cellular mechanisms that underlie Down syndrome and its link to early-onset Alzheimer's disease. By investigating the role of epigenetic regulation at critical genes on chromosome 21, the lab aims to elucidate how variations in gene expression may contribute to the symptoms associated with these conditions. This research not only advances our understanding of these diseases but also holds potential for developing new therapeutic strategies.